Innovent Biologics
信达生物
Innovent BiologicsCompany
信达生物
No graph yet
Mentioned in 3 articles
Coverage
FreeS Fund's Li Feng 2025 Year-End Share: The Logic and Outlook of AI Investment
Why Is This AI Boom Unprecedented? What Happens Next for AI Investment?
峰瑞资本·Deep Dive: China's "DeepSeek Moment" in Biotech | FreeS Fund Report
A Watershed Year for China's Innovative Drug Industry
峰瑞资本·Hongshan Healthcare Investing: 17 Years From the Sidelines to Center Stage
Going earlier and deeper has become a defining feature of Hongshan's healthcare investments.
暗涌Waves·
